IRCT20221105056406N1
Completed
Phase 2
Comparison of phenobarbital and levetiracetam in children with febrile seizures
Sabzevar University of Medical Sciences0 sites100 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Febrile convulsion(F.C).
- Sponsor
- Sabzevar University of Medical Sciences
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 6 months to 60 months
- •Convulsions followed by fever
Exclusion Criteria
- •Unwillingness to participate in the study
- •History of head trauma
- •Diseases of the central nervous system
- •Having diabetes
- •Suffering from certain diseases
- •Taking medicines for specific diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Comparison of effects of phenobarbital and levetiracetam in neonatal seizure controlIRCT20200528047589N1Mashhad University of Medical Sciences74
Recruiting
Phase 3
comparison of levetiracetam with phenobarbitone in neonatal seizureHealth Condition 1: null- all neonates with convulsion of any causeCTRI/2013/01/003310I80
Completed
Not Applicable
A clinical trial to compare the efficacy of phenobarbitone with levetiracetam for the treatment of seizures (fits) in newbornsHealth Condition 1: null- neonatal seizuresCTRI/2011/07/001863DR AMIT UPADHYAY60
Recruiting
Phase 4
Comparision between phenobarbitone and levetiracetam as the intial anti convulsant in treating preterm neonatal seizuresHealth Condition 1: P90- Convulsions of newbornCTRI/2021/02/031290Gummalla Gyandeep
Recruiting
Phase 3
Comparison of intravenous levetiracetam and phenobarbital in neonatal seizureseonatal Seizures.Epilepsy and recurrent seizuresIRCT20190526043717N1Ghoum University of Medical Sciences100